Compare DexCom, Inc. (DXCM) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Toronto-Dominion Bank — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 5.9× DexCom, Inc.'s market cap, and Toronto-Dominion Bank pays a 2.63% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | TD | |
|---|---|---|
Market Cap | $33.79B | $200.48B |
Sector | Health | Financials |
52-Week High | $89.53 | $124.80 |
52-Week Low | $54.84 | $72.85 |
Enterprise Value | $33.24B | — |
Dividend Yield | — | 2.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
